International estimates of intended uptake and refusal of COVID-19 vaccines: A rapid systematic review and meta-analysis of large nationally representative samples
Vaccines have been developed in unprecedented time and quantifying levels of hesitancy towards vaccination among the general population is of importance.
Global Recommendations on COVID-19 Vaccines and Soft Tissue Filler Reactions: A Survey-Based Investigation in Cooperation With the International Society for Dermatologic and Aesthetic Surgery (ISDS)
Concerns have been expressed about the association of soft tissue filler injections and the COVID-19 vaccines. The International Society for Dermatologic and Aesthetic Surgery understands these concerns. The data collected does not support the concern for an increased risk of developing adverse reactions following soft tissue. filler injections associated with the CoVid vaccines compared to that risk associated with other previously described triggers or the default risk. J Drugs Dermatol. 20(4)
Vaccine Hesitancy and Demand for Immunization in Eastern Europe and Central Asia: Implications for the Region and Beyond
Vaccine hesitancy has become a growing concern globally. It calls into question the safety and efficacy of vaccines. It threatens the progress made in combating morbidity and mortality including efforts to introduce COVID-19 vaccines.Recommendations include strengthen social listening and digital engagement to address the concerns of caregivers and healthcare professionals.
COVID-19 vaccines: Global challenges and prospects forum recommendations
The 11th KAIMRC Annual Research Forum Themed "COVID-19 Vaccine: Global Challenges and Prospects Forum" discussed COVID19 Vaccines. The Forum was held to shed light on these vaccines as many are at the late stage of Phase III clinical trials and ready to be marketed.
COVID-19 vaccines: Global challenges and prospects forum recommendations
The 11th KAIMRC Annual Research Forum Themed "COVID-19 Vaccine: Global Challenges and Prospects Forum" discussed COVID19 Vaccines. The Forum was held to shed light on these vaccines as many are at the late stage of Phase III clinical trials and ready to be marketed.
People's Willingness to Vaccinate Against COVID-19 Despite Their Safety Concerns: Twitter Poll Analysis
World Health Organization declared COVID-19 a global health emergency on January 30, 2020. By December 2020, the safety and efficacy of the first vaccines were demonstrated. Twitter polling system has provided a viable method for gaining rapid, large-scale, international public health insights on highly relevant and timely SARS-CoV-2-related topics. Since people's perceptions and views are strongly influenced by social media, the snapshots provided by these media platforms represent a static ima
Glucocorticoid use in patients with adrenal insufficiency following administration of the COVID-19 vaccine: a pituitary society statement
Pain at the injection site, fatigue, headache, myalgias, arthralgias, chills, and fever can be early indicators of an increased need for glucocorticoid replacement in patients with adrenal insufficiency. The Pituitary Society surveyed its membership to understand planned approaches to glucoc Corticoid management in patients who will receive a COVID-19 vaccine.
A prospective, single-blind trial comparing wireless capsule endoscopy and double-balloon enteroscopy in patients with obscure gastrointestinal bleeding
Wireless capsule endoscopy and double-balloon enteroscopy are new diagnostic methods. We compared the clinical efficacy of CE and DBE. CE revealed abnormal findings in 29 (90.6%) of 32 patients.